Skip to main content
Top
Published in: Critical Care 4/2012

Open Access 01-08-2012 | Research

Endotoxemia and mortality prediction in ICU and other settings: underlying risk and co-detection of gram negative bacteremia are confounders

Authors: James C Hurley, Bertrand Guidet, Georges Offenstadt, Eric Maury

Published in: Critical Care | Issue 4/2012

Login to get access

Abstract

Introduction

The interdependence between endotoxemia, gram negative (GN) bacteremia and mortality has been extensively studied. Underlying patient risk and GN bacteremia types are possible confounders of the relationship.

Methods

Published studies with ≥10 patients in either ICU or non-ICU settings, endotoxemia detection by limulus assay, reporting mortality proportions and ≥1 GN bacteremia were included. Summary odds ratios (OR) for mortality were derived across all studies by meta-analysis for the following contrasts: sub-groups with either endotoxemia (group three), GN bacteremia (group two) or both (group one) each versus the group with neither detected (group four; reference group). The mortality proportion for group four is the proxy measure of study level risk within L'Abbé plots.

Results

Thirty-five studies were found. Among nine studies in an ICU setting, the OR for mortality was borderline (OR <2) or non-significantly increased for groups two (GN bacteremia alone) and three (endotoxemia alone) and patient group one (GN bacteremia and endotoxemia co-detected) each versus patient group four (neither endotoxemia nor GN bacteremia detected). The ORs were markedly higher for group one versus group four (OR 6.9; 95% confidence interval (CI), 4.4 -to 11.0 when derived from non-ICU studies. The distributions of Pseudomonas aeruginosa and Escherichia coli bacteremias among groups one versus two are significantly unequal.

Conclusions

The co-detection of GN bacteremia and endotoxemia is predictive of increased mortality risk versus the detection of neither but only in studies undertaken in a non-ICU setting. Variation in GN bacteremia species types and underlying risk are likely unrecognized confounders in the individual studies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ahmed T, Azam MA, Armed N, Jamil KM, Hassan F, Ogura N, Tamura H, Yokochi T: Detection of endotoxin in sera from children hospitalized for treatment of diarrhea in Bangladesh. J Endotoxin Res. 2004, 10: 223-228.PubMedCrossRef Ahmed T, Azam MA, Armed N, Jamil KM, Hassan F, Ogura N, Tamura H, Yokochi T: Detection of endotoxin in sera from children hospitalized for treatment of diarrhea in Bangladesh. J Endotoxin Res. 2004, 10: 223-228.PubMedCrossRef
2.
go back to reference Casey WF, Hauser GJ, Hannallah RS, Midgley FM, Khan WN: Circulating endotoxin and tumor necrosis factor during pediatric cardiac surgery. Crit Care Med. 1992, 20: 1090-1096. 10.1097/00003246-199208000-00004.PubMedCrossRef Casey WF, Hauser GJ, Hannallah RS, Midgley FM, Khan WN: Circulating endotoxin and tumor necrosis factor during pediatric cardiac surgery. Crit Care Med. 1992, 20: 1090-1096. 10.1097/00003246-199208000-00004.PubMedCrossRef
3.
go back to reference Cooperstock M, Riegle L: Plasma limulus gelation assay in infants and children: correlation with gram negative bacterial infection and evidence for "intestinal endotoxemia". Prog Clin Biol Res. 1985, 189: 329-345.PubMed Cooperstock M, Riegle L: Plasma limulus gelation assay in infants and children: correlation with gram negative bacterial infection and evidence for "intestinal endotoxemia". Prog Clin Biol Res. 1985, 189: 329-345.PubMed
4.
go back to reference Klein K, Fuchs GJ, Kulapongs P, Mertz G, Suskind RM, Olson RE: Endotoxemia in protein-energy malnutrition. J Pediatr Gastroenterol Nutr. 1988, 7: 225-228. 10.1097/00005176-198803000-00012.PubMedCrossRef Klein K, Fuchs GJ, Kulapongs P, Mertz G, Suskind RM, Olson RE: Endotoxemia in protein-energy malnutrition. J Pediatr Gastroenterol Nutr. 1988, 7: 225-228. 10.1097/00005176-198803000-00012.PubMedCrossRef
5.
go back to reference Shenep JL, Flynn PM, Barrett FF, Stidham GL, Westenkirchner DF: Serial quantitation of endotoxemia and bacteremia during therapy for gram-negative bacterial sepsis. J Infect Dis. 1988, 157: 565-568. 10.1093/infdis/157.3.565.PubMedCrossRef Shenep JL, Flynn PM, Barrett FF, Stidham GL, Westenkirchner DF: Serial quantitation of endotoxemia and bacteremia during therapy for gram-negative bacterial sepsis. J Infect Dis. 1988, 157: 565-568. 10.1093/infdis/157.3.565.PubMedCrossRef
6.
go back to reference Bailey ME: Endotoxin, bile salts and renal function in obstructive jaundice. Br J Surg. 1976, 63: 774-778. 10.1002/bjs.1800631011.PubMedCrossRef Bailey ME: Endotoxin, bile salts and renal function in obstructive jaundice. Br J Surg. 1976, 63: 774-778. 10.1002/bjs.1800631011.PubMedCrossRef
7.
go back to reference Berger D, Boelke E, Stanescu A, Buttenschoen K, Vasilescu C, Seidelmann M, Beger HG: Endotoxemia and mediator release during colonoscopy. Endoscopy. 1995, 27: 671-675. 10.1055/s-2007-1005785.PubMedCrossRef Berger D, Boelke E, Stanescu A, Buttenschoen K, Vasilescu C, Seidelmann M, Beger HG: Endotoxemia and mediator release during colonoscopy. Endoscopy. 1995, 27: 671-675. 10.1055/s-2007-1005785.PubMedCrossRef
8.
go back to reference Foulis AK, Murray WR, Galloway D, McCartney AC, Lang E, Veitch J, Whaley K: Endotoxaemia and complement activation in acute pancreatitis in man. Gut. 1982, 23: 656-661. 10.1136/gut.23.8.656.PubMedPubMedCentralCrossRef Foulis AK, Murray WR, Galloway D, McCartney AC, Lang E, Veitch J, Whaley K: Endotoxaemia and complement activation in acute pancreatitis in man. Gut. 1982, 23: 656-661. 10.1136/gut.23.8.656.PubMedPubMedCentralCrossRef
9.
go back to reference Lau JY, Chung SC, Leung JW, Ling TK, Yung MY, Li AK: Endoscopic drainage aborts endotoxaemia in acute cholangitis. Br J Surg. 1996, 83: 181-184. 10.1002/bjs.1800830210.PubMedCrossRef Lau JY, Chung SC, Leung JW, Ling TK, Yung MY, Li AK: Endoscopic drainage aborts endotoxaemia in acute cholangitis. Br J Surg. 1996, 83: 181-184. 10.1002/bjs.1800830210.PubMedCrossRef
10.
go back to reference Lumsden AB, Henderson JM, Alspaugh J: Endotoxemia during percutaneous manipulation of the obstructed biliary tree. Am J Surg. 1989, 158: 21-24. 10.1016/0002-9610(89)90308-5.PubMedCrossRef Lumsden AB, Henderson JM, Alspaugh J: Endotoxemia during percutaneous manipulation of the obstructed biliary tree. Am J Surg. 1989, 158: 21-24. 10.1016/0002-9610(89)90308-5.PubMedCrossRef
11.
go back to reference Brandtzaeg P, Kierulf P, Gaustad P, Skulberg A, Bruun JN, Halvorsen S, Sorensen E: Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis. 1989, 159: 195-204. 10.1093/infdis/159.2.195.PubMedCrossRef Brandtzaeg P, Kierulf P, Gaustad P, Skulberg A, Bruun JN, Halvorsen S, Sorensen E: Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis. 1989, 159: 195-204. 10.1093/infdis/159.2.195.PubMedCrossRef
12.
go back to reference Brandtzaeg P, Hogasen K, Kierulf P, Mollnes TE: The excessive complement activation in fulminant meningococcal septicemia is predominantly caused by alternate pathway activation. J Infect Dis. 1996, 173: 647-655. 10.1093/infdis/173.3.647.PubMedCrossRef Brandtzaeg P, Hogasen K, Kierulf P, Mollnes TE: The excessive complement activation in fulminant meningococcal septicemia is predominantly caused by alternate pathway activation. J Infect Dis. 1996, 173: 647-655. 10.1093/infdis/173.3.647.PubMedCrossRef
13.
go back to reference Butler T, Levin J, Cu DQ, Walker RI: Bubonic plague: detection of endotoxemia with the limulus test. Ann Intern Med. 1973, 79: 642-646.PubMedCrossRef Butler T, Levin J, Cu DQ, Walker RI: Bubonic plague: detection of endotoxemia with the limulus test. Ann Intern Med. 1973, 79: 642-646.PubMedCrossRef
14.
go back to reference Butler T, Levin J, Linh NN, Chau DM, Adickman M, Arnold K: Yersinia pestis infection in Vietnam. II. Quantitative blood cultures and detection of endotoxin in the cerebrospinal fluid of patients with meningitis. J Infect Dis. 1976, 133: 493-499. 10.1093/infdis/133.5.493.PubMedCrossRef Butler T, Levin J, Linh NN, Chau DM, Adickman M, Arnold K: Yersinia pestis infection in Vietnam. II. Quantitative blood cultures and detection of endotoxin in the cerebrospinal fluid of patients with meningitis. J Infect Dis. 1976, 133: 493-499. 10.1093/infdis/133.5.493.PubMedCrossRef
15.
go back to reference Magliulo E, Scevola D, Fumarola D, Vaccaro R, Bertotto A, Burberi S: Clinical experience in detecting endotoxemia with the limulus test in typhoid fever and other Salmonella infections. Infection. 1976, 4: 21-24. 10.1007/BF01638343.PubMedCrossRef Magliulo E, Scevola D, Fumarola D, Vaccaro R, Bertotto A, Burberi S: Clinical experience in detecting endotoxemia with the limulus test in typhoid fever and other Salmonella infections. Infection. 1976, 4: 21-24. 10.1007/BF01638343.PubMedCrossRef
16.
go back to reference Adinolfi LE, Utili R, Gaeta GB, Perna P, Ruggiero G: Presence of endotoxemia and its relationship to liver dysfunction in patients with typhoid fever. Infection. 1987, 15: 359-362. 10.1007/BF01647740.PubMedCrossRef Adinolfi LE, Utili R, Gaeta GB, Perna P, Ruggiero G: Presence of endotoxemia and its relationship to liver dysfunction in patients with typhoid fever. Infection. 1987, 15: 359-362. 10.1007/BF01647740.PubMedCrossRef
17.
go back to reference Suyasa IG, Reka IG, Inada K, Suda H, Kojima M, Mushiaki K, Okamoto S, Yoshida M: Plasma endotoxin in typhoid fever. Kobe J Med Sci. 1995, 41: 175-186.PubMed Suyasa IG, Reka IG, Inada K, Suda H, Kojima M, Mushiaki K, Okamoto S, Yoshida M: Plasma endotoxin in typhoid fever. Kobe J Med Sci. 1995, 41: 175-186.PubMed
18.
go back to reference Bion JF, Badger I, Crosby HA, Hutchings P, Kong KL, Baker J, Hutton P, McMaster P, Buckels JA, Elliott TS: Selective decontamination of the digestive tract reduces gram-negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation. Crit Care Med. 1994, 22: 40-49.PubMed Bion JF, Badger I, Crosby HA, Hutchings P, Kong KL, Baker J, Hutton P, McMaster P, Buckels JA, Elliott TS: Selective decontamination of the digestive tract reduces gram-negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation. Crit Care Med. 1994, 22: 40-49.PubMed
19.
go back to reference Engervall P, Granstrom M, Andersson B, Kalin M, Bjorkholm M: Endotoxemia in febrile patients with hematological malignancies. Relationship of type of bacteremia, clinical findings and serum cytokine pattern. Infection. 1997, 25: 2-7. 10.1007/BF02113498.PubMedCrossRef Engervall P, Granstrom M, Andersson B, Kalin M, Bjorkholm M: Endotoxemia in febrile patients with hematological malignancies. Relationship of type of bacteremia, clinical findings and serum cytokine pattern. Infection. 1997, 25: 2-7. 10.1007/BF02113498.PubMedCrossRef
20.
go back to reference Hynninen M, Valtonen M, Vaara M, Markkanen H, Kuusela P, Saxen H, Takkunen O: Plasma endotoxin and cytokine levels in neutropenic and non-neutropenic bacteremic patients. Eur J Clin Micro Infect Dis. 1995, 14: 1039-1045. 10.1007/BF01590936.CrossRef Hynninen M, Valtonen M, Vaara M, Markkanen H, Kuusela P, Saxen H, Takkunen O: Plasma endotoxin and cytokine levels in neutropenic and non-neutropenic bacteremic patients. Eur J Clin Micro Infect Dis. 1995, 14: 1039-1045. 10.1007/BF01590936.CrossRef
21.
go back to reference Yoshida M, Obayashi T, Tamura H, Tanaka S, Kawai T, Sakamoto S, Miura Y: Diagnostic and prognostic significance of plasma endotoxin determination in febrile patients with haematological malignancies. Eur J Cancer. 1994, 30A: 145-147.PubMedCrossRef Yoshida M, Obayashi T, Tamura H, Tanaka S, Kawai T, Sakamoto S, Miura Y: Diagnostic and prognostic significance of plasma endotoxin determination in febrile patients with haematological malignancies. Eur J Cancer. 1994, 30A: 145-147.PubMedCrossRef
22.
go back to reference Byl B, Clevenbergh P, Kentos A, Jacobs F, Marchant A, Vincent JL, Thys JP: Ceftazidime- and imipenem-induced endotoxin release during treatment of gram-negative infections. Eur J Clin Microbiol Infect Dis. 2001, 20: 804-807. 10.1007/s100960100609.PubMedCrossRef Byl B, Clevenbergh P, Kentos A, Jacobs F, Marchant A, Vincent JL, Thys JP: Ceftazidime- and imipenem-induced endotoxin release during treatment of gram-negative infections. Eur J Clin Microbiol Infect Dis. 2001, 20: 804-807. 10.1007/s100960100609.PubMedCrossRef
23.
go back to reference Giamarellos-Bourboulis EJ, Perdios J, Lelekis M, Eoconomou E, Tsouroulas P, Giamarellou H: Impact of cefuroxime administration on endotoxin (LPS) and tumour necrosis factor-a (TNF-a) blood levels in patients suffering from acute pyelonephritis: a preliminary report. Int J Antimicrob Agents. 1999, 11: 115-119. 10.1016/S0924-8579(98)00106-X.CrossRef Giamarellos-Bourboulis EJ, Perdios J, Lelekis M, Eoconomou E, Tsouroulas P, Giamarellou H: Impact of cefuroxime administration on endotoxin (LPS) and tumour necrosis factor-a (TNF-a) blood levels in patients suffering from acute pyelonephritis: a preliminary report. Int J Antimicrob Agents. 1999, 11: 115-119. 10.1016/S0924-8579(98)00106-X.CrossRef
24.
go back to reference Levin J, Poore TE, Young NS, Margolis S, Zauber NP, Townes AS, Bell WR: Gram-negative sepsis: detection of endotoxemia with the limulus test. With studies of associated changes in blood coagulation, serum lipids and complement. Ann Intern Med. 1972, 76: 1-7.PubMedCrossRef Levin J, Poore TE, Young NS, Margolis S, Zauber NP, Townes AS, Bell WR: Gram-negative sepsis: detection of endotoxemia with the limulus test. With studies of associated changes in blood coagulation, serum lipids and complement. Ann Intern Med. 1972, 76: 1-7.PubMedCrossRef
25.
go back to reference Stumacher RJ, Kovnat MJ, McCabe WR: Limitations of the usefulness of the limulus assay for endotoxin. N Engl J Med. 1973, 288: 1261-1264. 10.1056/NEJM197306142882402.PubMedCrossRef Stumacher RJ, Kovnat MJ, McCabe WR: Limitations of the usefulness of the limulus assay for endotoxin. N Engl J Med. 1973, 288: 1261-1264. 10.1056/NEJM197306142882402.PubMedCrossRef
26.
go back to reference van Langevelde P, Joop K, van Loon J, Frolich M, Groeneveld PHP, Westendorp RGJ, van Dissel JT: Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital: identification of subjects at high risk of mortality. Clin Infect Dis. 2000, 31: 1343-1348. 10.1086/317480.PubMedCrossRef van Langevelde P, Joop K, van Loon J, Frolich M, Groeneveld PHP, Westendorp RGJ, van Dissel JT: Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital: identification of subjects at high risk of mortality. Clin Infect Dis. 2000, 31: 1343-1348. 10.1086/317480.PubMedCrossRef
27.
go back to reference Bates DW, Parsonnet J, Ketchum PA, Novitsky TJ, Sands K, Hibberd PL, Graman PS, Lanken PN: Limulus amebocyte lysate assay for detection of endotoxin in patients with sepsis syndrome. AMCC Sepsis Project Working Group. Clin Infect Dis. 1998, 27: 582-591. 10.1086/514713.PubMedCrossRef Bates DW, Parsonnet J, Ketchum PA, Novitsky TJ, Sands K, Hibberd PL, Graman PS, Lanken PN: Limulus amebocyte lysate assay for detection of endotoxin in patients with sepsis syndrome. AMCC Sepsis Project Working Group. Clin Infect Dis. 1998, 27: 582-591. 10.1086/514713.PubMedCrossRef
28.
go back to reference Billard J-L, Berthier-Berrada S, Page Y, Géry P, Vermesch R, Page D, Ros A, Bertrand M, Bertrand JC: Endotoxemia in human septic shock: relation to gastric intra-mucosal pH. Crit Care Med. 1994, 22: A113-CrossRef Billard J-L, Berthier-Berrada S, Page Y, Géry P, Vermesch R, Page D, Ros A, Bertrand M, Bertrand JC: Endotoxemia in human septic shock: relation to gastric intra-mucosal pH. Crit Care Med. 1994, 22: A113-CrossRef
29.
go back to reference Danner RL, Elin RJ, Hosseini JM, Wesley RA, Reilly JM, Parilllo JE: Endotoxemia in human septic shock. Chest. 1991, 99: 169-175. 10.1378/chest.99.1.169.PubMedCrossRef Danner RL, Elin RJ, Hosseini JM, Wesley RA, Reilly JM, Parilllo JE: Endotoxemia in human septic shock. Chest. 1991, 99: 169-175. 10.1378/chest.99.1.169.PubMedCrossRef
30.
go back to reference Dofferhoff AS, Bom VJ, de Vries-Hospers HG, van Ingen J, vd Meer J, Hazenberg BP, Mulder PO, Weits J: Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute phase proteins during the treatment of severe sepsis in humans. Crit Care Med. 1992, 20: 185-192. 10.1097/00003246-199202000-00007.PubMedCrossRef Dofferhoff AS, Bom VJ, de Vries-Hospers HG, van Ingen J, vd Meer J, Hazenberg BP, Mulder PO, Weits J: Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute phase proteins during the treatment of severe sepsis in humans. Crit Care Med. 1992, 20: 185-192. 10.1097/00003246-199202000-00007.PubMedCrossRef
31.
go back to reference Goldie AS, Fearon KC, Ross JA, Barclay GR, Jackson RE, Grant IS, Ramsay G, Blyth AS, Howie JC: Natural cytokine antagonists and endogenous anti-endotoxin core antibodies in sepsis syndrome. JAMA. 1995, 274: 172-177. 10.1001/jama.1995.03530020090038.PubMedCrossRef Goldie AS, Fearon KC, Ross JA, Barclay GR, Jackson RE, Grant IS, Ramsay G, Blyth AS, Howie JC: Natural cytokine antagonists and endogenous anti-endotoxin core antibodies in sepsis syndrome. JAMA. 1995, 274: 172-177. 10.1001/jama.1995.03530020090038.PubMedCrossRef
32.
go back to reference Guidet B, Barakett V, Vassal T, Petit JC, Offenstadt G: Endotoxemia and bacteremia in patients with sepsis syndrome in the intensive care unit. Chest. 1994, 106: 1194-1201. 10.1378/chest.106.4.1194.PubMedCrossRef Guidet B, Barakett V, Vassal T, Petit JC, Offenstadt G: Endotoxemia and bacteremia in patients with sepsis syndrome in the intensive care unit. Chest. 1994, 106: 1194-1201. 10.1378/chest.106.4.1194.PubMedCrossRef
33.
go back to reference Strutz F, Heller G, Krasemann K, Krone B, Muller GA: Relationship of antibodies to endotoxin core to mortality in medical patients with sepsis syndrome. Intensive Care Med. 1999, 25: 435-444. 10.1007/s001340050877.PubMedCrossRef Strutz F, Heller G, Krasemann K, Krone B, Muller GA: Relationship of antibodies to endotoxin core to mortality in medical patients with sepsis syndrome. Intensive Care Med. 1999, 25: 435-444. 10.1007/s001340050877.PubMedCrossRef
34.
go back to reference Wortel CH, von der Mohlen MA, van Deventer SJ, Sprung CL, Jastremski M, Lubbers MJ, Smith CR, Allen IE, ten Cate JW: Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in Gram-negative sepsis: relationship to endotoxin and cytokine levels. J Infect Dis. 1992, 166: 1367-1374. 10.1093/infdis/166.6.1367.PubMedCrossRef Wortel CH, von der Mohlen MA, van Deventer SJ, Sprung CL, Jastremski M, Lubbers MJ, Smith CR, Allen IE, ten Cate JW: Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in Gram-negative sepsis: relationship to endotoxin and cytokine levels. J Infect Dis. 1992, 166: 1367-1374. 10.1093/infdis/166.6.1367.PubMedCrossRef
35.
go back to reference Opal SM, Scannon PJ, Vincent JL, White M, Carroll SF, Palardy JE, Parejo NA, Pribble JP, Lemke JH: Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis. 1999, 180: 1584-1589. 10.1086/315093.PubMedCrossRef Opal SM, Scannon PJ, Vincent JL, White M, Carroll SF, Palardy JE, Parejo NA, Pribble JP, Lemke JH: Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis. 1999, 180: 1584-1589. 10.1086/315093.PubMedCrossRef
36.
go back to reference Casey LC, Balk RA, Bone RC: Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med. 1993, 119: 771-778.PubMedCrossRef Casey LC, Balk RA, Bone RC: Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med. 1993, 119: 771-778.PubMedCrossRef
37.
go back to reference Kollef MH, Eisenberg PR: A rapid quantitative assay to detect circulating endotoxin can predict the development of multiorgan dysfunction. Chest. 1997, 112: 173-180. 10.1378/chest.112.1.173.PubMedCrossRef Kollef MH, Eisenberg PR: A rapid quantitative assay to detect circulating endotoxin can predict the development of multiorgan dysfunction. Chest. 1997, 112: 173-180. 10.1378/chest.112.1.173.PubMedCrossRef
38.
go back to reference Marshall JC, Foster D, Vincent JL, Cook DJ, Cohen J, Dellinger RP, Opal S, Abraham E, Brett SJ, Smith T, Mehta S, Derzko A, Romaschin A: Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis. 2004, 190: 527-534. 10.1086/422254.PubMedCrossRef Marshall JC, Foster D, Vincent JL, Cook DJ, Cohen J, Dellinger RP, Opal S, Abraham E, Brett SJ, Smith T, Mehta S, Derzko A, Romaschin A: Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis. 2004, 190: 527-534. 10.1086/422254.PubMedCrossRef
39.
go back to reference Venet C, Zeni F, Viallon A, Ross A, Pain P, Gery P, Page D, Vermesch R, Bertrand M, Rancon F, Bertrand JC: Endotoxaemia in patients with severe sepsis or septic shock. Intensive Care Med. 2000, 26: 538-544. 10.1007/s001340051201.PubMedCrossRef Venet C, Zeni F, Viallon A, Ross A, Pain P, Gery P, Page D, Vermesch R, Bertrand M, Rancon F, Bertrand JC: Endotoxaemia in patients with severe sepsis or septic shock. Intensive Care Med. 2000, 26: 538-544. 10.1007/s001340051201.PubMedCrossRef
40.
go back to reference van Deventer SJH, Buller HR, ten Cate JW, Sturk A, Pauw W: Endotoxemia: an early predictor of septicemia in febrile patients. Lancet. 1988, 1: 605-608.PubMedCrossRef van Deventer SJH, Buller HR, ten Cate JW, Sturk A, Pauw W: Endotoxemia: an early predictor of septicemia in febrile patients. Lancet. 1988, 1: 605-608.PubMedCrossRef
41.
go back to reference Elin RJ, Robinson RA, Levine AS, Wolff SM: Lack of clinical usefulness of the limulus test in the diagnosis of endotoxemia. N Engl J Med. 1975, 293: 521-524. 10.1056/NEJM197509112931102.PubMedCrossRef Elin RJ, Robinson RA, Levine AS, Wolff SM: Lack of clinical usefulness of the limulus test in the diagnosis of endotoxemia. N Engl J Med. 1975, 293: 521-524. 10.1056/NEJM197509112931102.PubMedCrossRef
42.
go back to reference Hurley JC: Does gram negative bacteremia occur without endotoxemia? A meta-analysis using hierarchical summary ROC curves. Eur J Clin Microbiol Infect Dis. 2010, 29: 207-215. 10.1007/s10096-009-0841-2.PubMedCrossRef Hurley JC: Does gram negative bacteremia occur without endotoxemia? A meta-analysis using hierarchical summary ROC curves. Eur J Clin Microbiol Infect Dis. 2010, 29: 207-215. 10.1007/s10096-009-0841-2.PubMedCrossRef
43.
go back to reference Hurley JC: The detection of endotoxemia with Gram negative bacteremia is bacterial species dependent: A meta-analysis of clinical studies. J Clin Microbiol. 2009, 47: 3826-3831. 10.1128/JCM.01189-09.PubMedPubMedCentralCrossRef Hurley JC: The detection of endotoxemia with Gram negative bacteremia is bacterial species dependent: A meta-analysis of clinical studies. J Clin Microbiol. 2009, 47: 3826-3831. 10.1128/JCM.01189-09.PubMedPubMedCentralCrossRef
45.
46.
go back to reference Kim PW, Perl TM, Keelaghan EF, Langenberg P, Perencevich EN, Harris AD, Song X, Roghmann MC: Risk of mortality with blood stream infection is higher in the less severely ill at admission. Am J Respir Crit Care Med. 2005, 171: 616-620.PubMedCrossRef Kim PW, Perl TM, Keelaghan EF, Langenberg P, Perencevich EN, Harris AD, Song X, Roghmann MC: Risk of mortality with blood stream infection is higher in the less severely ill at admission. Am J Respir Crit Care Med. 2005, 171: 616-620.PubMedCrossRef
47.
go back to reference McCabe WR, Jackson GG: Gram negative bacteremia. II Clinical laboratory and therapeutic observations. Arch Intern Med. 1962, 110: 856-864. 10.1001/archinte.1962.03620240038007.CrossRef McCabe WR, Jackson GG: Gram negative bacteremia. II Clinical laboratory and therapeutic observations. Arch Intern Med. 1962, 110: 856-864. 10.1001/archinte.1962.03620240038007.CrossRef
48.
go back to reference Eichacker PQ, Parent C, Kalil A, Esposito C, Cui X, Banks SM, Gertenberger EP, Fitz Y, Danner RL, Natanson C: Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis. Am J Respir Crit Care Med. 2002, 166: 1197-1205. 10.1164/rccm.200204-302OC.PubMedCrossRef Eichacker PQ, Parent C, Kalil A, Esposito C, Cui X, Banks SM, Gertenberger EP, Fitz Y, Danner RL, Natanson C: Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis. Am J Respir Crit Care Med. 2002, 166: 1197-1205. 10.1164/rccm.200204-302OC.PubMedCrossRef
49.
go back to reference Dyson A, Singer M: Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting?. Crit Care Med. 2009, 37: S30-S37. 10.1097/CCM.0b013e3181922bd3.PubMedCrossRef Dyson A, Singer M: Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting?. Crit Care Med. 2009, 37: S30-S37. 10.1097/CCM.0b013e3181922bd3.PubMedCrossRef
50.
go back to reference Rittirsch D, Hoesel LM, Ward PA: The disconnect between animal models of sepsis and human sepsis. J Leukoc Biol. 2007, 81: 137-143.PubMedCrossRef Rittirsch D, Hoesel LM, Ward PA: The disconnect between animal models of sepsis and human sepsis. J Leukoc Biol. 2007, 81: 137-143.PubMedCrossRef
51.
go back to reference Michie HR: The value of animal models in the development of new drugs for the treatment of the sepsis syndrome. J Antimicrob Chemother. 1998, 41 (suppl 1): 47-49. 10.1093/jac/41.suppl_1.47.PubMedCrossRef Michie HR: The value of animal models in the development of new drugs for the treatment of the sepsis syndrome. J Antimicrob Chemother. 1998, 41 (suppl 1): 47-49. 10.1093/jac/41.suppl_1.47.PubMedCrossRef
52.
53.
go back to reference Hurley JC: Endotoxemia and gram-negative bacteremias predictors of outcome in sepsis: a call for data. J Endotox Res. 2001, 7: 467-CrossRef Hurley JC: Endotoxemia and gram-negative bacteremias predictors of outcome in sepsis: a call for data. J Endotox Res. 2001, 7: 467-CrossRef
54.
go back to reference Harris RJ, Bradburn MJ, Deeks JJ, Harbord RM, Altmamn DG, Sterne JAC: Metan: fixed and random effects-meta-analysis. Stata J. 2008, 8: 3-28. Harris RJ, Bradburn MJ, Deeks JJ, Harbord RM, Altmamn DG, Sterne JAC: Metan: fixed and random effects-meta-analysis. Stata J. 2008, 8: 3-28.
56.
go back to reference L'Abbe KA, Detsky AS, O'Rourke K: Meta-analysis in clinical research. Ann Intern Med. 1987, 107: 224-233.PubMedCrossRef L'Abbe KA, Detsky AS, O'Rourke K: Meta-analysis in clinical research. Ann Intern Med. 1987, 107: 224-233.PubMedCrossRef
57.
go back to reference Hurley JC: Endotoxemia and Gram-negative bacteremia as predictors of outcome in sepsis: a meta-analysis using ROC curves. J Endotoxin Res. 2003, 9: 271-279.PubMedCrossRef Hurley JC: Endotoxemia and Gram-negative bacteremia as predictors of outcome in sepsis: a meta-analysis using ROC curves. J Endotoxin Res. 2003, 9: 271-279.PubMedCrossRef
58.
go back to reference Schedel I, Dreikhausen U, Nentwig B, Höckenschnieder M, Rauthmann D, Balikcioglu S, Coldewey R, Deicher H: Treatment of gram-negative septic shock with an immunoglobulin preparation: a prospective, randomized clinical trial. Crit Care Med. 1991, 19: 1104-1113. 10.1097/00003246-199109000-00003.PubMedCrossRef Schedel I, Dreikhausen U, Nentwig B, Höckenschnieder M, Rauthmann D, Balikcioglu S, Coldewey R, Deicher H: Treatment of gram-negative septic shock with an immunoglobulin preparation: a prospective, randomized clinical trial. Crit Care Med. 1991, 19: 1104-1113. 10.1097/00003246-199109000-00003.PubMedCrossRef
59.
go back to reference Roberts FJ, Geere IW, Coldman A: A three-year study of positive blood cultures, with emphasis on prognosis. Rev Infect Dis. 1991, 13: 34-46.PubMedCrossRef Roberts FJ, Geere IW, Coldman A: A three-year study of positive blood cultures, with emphasis on prognosis. Rev Infect Dis. 1991, 13: 34-46.PubMedCrossRef
60.
go back to reference Cohen J, Cristofaro P, Carlet J, Opal S: New method of classifying infections in critically ill patients. Crit Care Med. 2001, 32: 1510-1526.CrossRef Cohen J, Cristofaro P, Carlet J, Opal S: New method of classifying infections in critically ill patients. Crit Care Med. 2001, 32: 1510-1526.CrossRef
61.
go back to reference Miller PJ, Wenzel RP: Etiologic organisms as independent predictors of death and morbidity associated with bloodstream infections. J Infect Dis. 1987, 156: 471-477. 10.1093/infdis/156.3.471.PubMedCrossRef Miller PJ, Wenzel RP: Etiologic organisms as independent predictors of death and morbidity associated with bloodstream infections. J Infect Dis. 1987, 156: 471-477. 10.1093/infdis/156.3.471.PubMedCrossRef
62.
go back to reference Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW: Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother. 2005, 49: 760-766. 10.1128/AAC.49.2.760-766.2005.PubMedPubMedCentralCrossRef Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW: Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother. 2005, 49: 760-766. 10.1128/AAC.49.2.760-766.2005.PubMedPubMedCentralCrossRef
63.
go back to reference Micek ST, Lloyd AE, Ritchie DJ, Reichley RM, Fraser VJ, Kollef MH: Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother. 2005, 49: 1306-1311. 10.1128/AAC.49.4.1306-1311.2005.PubMedPubMedCentralCrossRef Micek ST, Lloyd AE, Ritchie DJ, Reichley RM, Fraser VJ, Kollef MH: Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother. 2005, 49: 1306-1311. 10.1128/AAC.49.4.1306-1311.2005.PubMedPubMedCentralCrossRef
64.
go back to reference Dehus O, Hartung T, Hermann C: Endotoxin evaluation of eleven lipopolysaccharides by whole blood assay does not always correlate with Limulus amebocyte lysate assay. J Endotoxin Res. 2006, 12: 171-180. 10.1179/096805106X102156.PubMedCrossRef Dehus O, Hartung T, Hermann C: Endotoxin evaluation of eleven lipopolysaccharides by whole blood assay does not always correlate with Limulus amebocyte lysate assay. J Endotoxin Res. 2006, 12: 171-180. 10.1179/096805106X102156.PubMedCrossRef
65.
go back to reference Devleeschouwer MJ, Cornil MF, Dony J: Studies on the sensitivity and specificity of the Limulus amebocyte lysate test and rabbit pyrogen assays. Appl Environ Microbiol. 1985, 50: 1509-1511.PubMedPubMedCentral Devleeschouwer MJ, Cornil MF, Dony J: Studies on the sensitivity and specificity of the Limulus amebocyte lysate test and rabbit pyrogen assays. Appl Environ Microbiol. 1985, 50: 1509-1511.PubMedPubMedCentral
66.
go back to reference Danner RL, Natanson C, Elin RJ, Hosseini JM, Banks S, MacVittie TJ, Parrillo JE: Pseudomonas aeruginosa compared with Escherichia coli produces less endotoxemia but more cardiovascular dysfunction and mortality in a canine model of septic shock. Chest. 1990, 98: 1480-1487. 10.1378/chest.98.6.1480.PubMedCrossRef Danner RL, Natanson C, Elin RJ, Hosseini JM, Banks S, MacVittie TJ, Parrillo JE: Pseudomonas aeruginosa compared with Escherichia coli produces less endotoxemia but more cardiovascular dysfunction and mortality in a canine model of septic shock. Chest. 1990, 98: 1480-1487. 10.1378/chest.98.6.1480.PubMedCrossRef
67.
go back to reference Fine J, Frank ED, Ravin HA, Rutenberg SH, Schweinburg FB: The bacterial factor in traumatic shock. N Engl J Med. 1959, 260: 214-220. 10.1056/NEJM195901292600505.PubMedCrossRef Fine J, Frank ED, Ravin HA, Rutenberg SH, Schweinburg FB: The bacterial factor in traumatic shock. N Engl J Med. 1959, 260: 214-220. 10.1056/NEJM195901292600505.PubMedCrossRef
68.
go back to reference Klein DJ, Derzko A, Foster D, Seely AJ, Brunet F, Romaschin AD, Marshall JC: Daily variation in endotoxin levels is associated with increased organ failure in critically ill patients. Shock. 2007, 28: 524-529.PubMed Klein DJ, Derzko A, Foster D, Seely AJ, Brunet F, Romaschin AD, Marshall JC: Daily variation in endotoxin levels is associated with increased organ failure in critically ill patients. Shock. 2007, 28: 524-529.PubMed
69.
go back to reference Sharp SJ, Thompson SG: Analysing the relationship between treatment effect and underlying risk in meta-analysis: comparison and development of approaches. Stat Med. 2000, 19: 3251-3274. 10.1002/1097-0258(20001215)19:23<3251::AID-SIM625>3.0.CO;2-2.PubMedCrossRef Sharp SJ, Thompson SG: Analysing the relationship between treatment effect and underlying risk in meta-analysis: comparison and development of approaches. Stat Med. 2000, 19: 3251-3274. 10.1002/1097-0258(20001215)19:23<3251::AID-SIM625>3.0.CO;2-2.PubMedCrossRef
70.
go back to reference Song F: Exploring heterogeneity in meta-analysis: is the L'Abbé plotuUseful?. J Clin Epidemiol. 1999, 58: 717-723. Song F: Exploring heterogeneity in meta-analysis: is the L'Abbé plotuUseful?. J Clin Epidemiol. 1999, 58: 717-723.
71.
go back to reference Egger M, Davey Smith G: Risks and benefits of treating mild hypertension: a misleading meta-analysis?. J Hypertension. 1995, 13: 813-815. 10.1097/00004872-199507000-00014.CrossRef Egger M, Davey Smith G: Risks and benefits of treating mild hypertension: a misleading meta-analysis?. J Hypertension. 1995, 13: 813-815. 10.1097/00004872-199507000-00014.CrossRef
72.
go back to reference Barnett AG, van der Pols JC, Dobson AJ: Regression to the mean: what it is and how to deal with it. Int J Epidemiol. 2005, 34: 215-220.PubMedCrossRef Barnett AG, van der Pols JC, Dobson AJ: Regression to the mean: what it is and how to deal with it. Int J Epidemiol. 2005, 34: 215-220.PubMedCrossRef
73.
go back to reference Maury E, Blanchard HS, Chauvin P, Guglielminotti J, Alzieu M, Guidet B, Offenstadt G: Circulating endotoxin and antiendotoxin antibodies during severe sepsis and septic shock. J Crit Care. 2003, 18: 115-120. 10.1053/jcrc.2003.50004.PubMedCrossRef Maury E, Blanchard HS, Chauvin P, Guglielminotti J, Alzieu M, Guidet B, Offenstadt G: Circulating endotoxin and antiendotoxin antibodies during severe sepsis and septic shock. J Crit Care. 2003, 18: 115-120. 10.1053/jcrc.2003.50004.PubMedCrossRef
74.
go back to reference Warren HS, Danner RL, Munford RS: Anti-endotoxin monoclonal antibodies. N Engl J Med. 1992, 326: 1153-1157. 10.1056/NEJM199204233261711.PubMedCrossRef Warren HS, Danner RL, Munford RS: Anti-endotoxin monoclonal antibodies. N Engl J Med. 1992, 326: 1153-1157. 10.1056/NEJM199204233261711.PubMedCrossRef
75.
go back to reference Opal S, Gluck T: Endotoxin as a drug target. Crit Care Med. 2003, 31: S57-S64. 10.1097/00003246-200301001-00009.PubMedCrossRef Opal S, Gluck T: Endotoxin as a drug target. Crit Care Med. 2003, 31: S57-S64. 10.1097/00003246-200301001-00009.PubMedCrossRef
76.
go back to reference Hurley JC: Reappraisal of the role of endotoxin in the sepsis syndrome. Lancet. 1993, 341: 1133-1135. 10.1016/0140-6736(93)93139-R.PubMedCrossRef Hurley JC: Reappraisal of the role of endotoxin in the sepsis syndrome. Lancet. 1993, 341: 1133-1135. 10.1016/0140-6736(93)93139-R.PubMedCrossRef
Metadata
Title
Endotoxemia and mortality prediction in ICU and other settings: underlying risk and co-detection of gram negative bacteremia are confounders
Authors
James C Hurley
Bertrand Guidet
Georges Offenstadt
Eric Maury
Publication date
01-08-2012
Publisher
BioMed Central
Published in
Critical Care / Issue 4/2012
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc11462

Other articles of this Issue 4/2012

Critical Care 4/2012 Go to the issue